Pfizer (Germany) Today
| PFE Stock | EUR 25.60 0.18 0.71% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Pfizer is selling for under 25.60 as of the 20th of January 2025; that is 0.71 percent increase since the beginning of the trading day. The stock's last reported lowest price was 25.58. Pfizer has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 20th of January 2025. Click here to learn more.
Moving against Pfizer Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pfizer Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pfizer's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pfizer or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Other, Other (View all Sectors) |
Pfizer Inc (PFE) is traded on Munich Exchange in Germany and employs 34 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 262.32 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pfizer Inc operates under Other sector and is part of Other industry.
Pfizer generates positive cash flow from operations, but has no cash available
Check Pfizer Probability Of Bankruptcy
Pfizer Inc Risk Profiles
Although Pfizer's alpha and beta are two of the key measurements used to evaluate Pfizer's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9426 | |||
| Standard Deviation | 1.33 | |||
| Variance | 1.77 | |||
| Risk Adjusted Performance | (0.01) |
Pfizer Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pfizer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Additional Tools for Pfizer Stock Analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.